Bioxytran (BIXT) Non-cash Items (2023)

Bioxytran (BIXT) posted Non-cash Items of $100837.0 for Q4 2023.

Bioxytran (BIXT) Non-cash Items (2023) Analysis & Trends

Bioxytran has reported Non-cash Items for 1 years, with the latest figure at $100837.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn
8	Royalty Pharma	26.98 Bn	26.14 Bn	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn
10	Bioxytran	2.47 Mn	2.22 Mn	-

Download Data

Date	Value
Dec 31, 2023	100,837.00
Dec 31, 2023	100,837.00